A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment 1 1MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.-Reference-Cited by-同舟云学术

A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment 1 1MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.

Published:2017-01 Issue:1 Volume:35 Page:14-20
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Zhou Tian C.,Sankin Alexander I.,Porcelli Steven A.,Perlin David S.,Schoenberg Mark P.,Zang Xingxing

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference50 articles.

1. Howlader N, Noone AM, Krapcho M: SEER Cancer Statistics Review, April 2015 ed. Bethesda: National Cancer Institute; 1975–2012.

2. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

3. Coley’s toxins in perspective;Starnes;Nature,1992

4. Cancer and tuberculosis;Raymond;Am J Hygiene,1929

5. Effect of bacillus Calmette-Guerin infection on transplanted tumours in the mouse;Old;Nature,1959

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE EFFECT OF IMMUNOLOGICAL BIOMARKERS - NLR, PLR, LMR, PD-L1 ON THE SURVIVAL OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER;Themed collection of papers from Foreign International Scientific Conference «Modern research on the way to a new scientific revolution». Part 2. by HNRI «National development» in cooperation with AFP (Puerto Cabezas, Nicaragua). November 2023. – Varadero (Cuba);2024-01-23

2. The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment;Urologic Oncology: Seminars and Original Investigations;2023-12

3. Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration;Scientific Reports;2023-09-05

4. Comprehensive analyses of genome-wide methylation and RNA epigenetics identify prognostic biomarkers, regulating the tumor immune microenvironment in lung adenocarcinoma;Pathology - Research and Practice;2023-08

5. Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans;Cancer Research Communications;2023-05-15